Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
Wednesday, November 06, 2013
The strategies and timing of outsourcing pharmaceutical development processes to a contract testing laboratory will be the focus of a mini-workshop at the 2013 AAPS Annual Meeting and Exposition on Nov. 12, 2013.
read more
Monday, November 11, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces Jesse McCool as Vice President of Microbial Services.
read more
Friday, November 15, 2013
ordenPharma acquired Ancora Pharmaceuticals, located in Woburn, MA, USA. Ancora’s unique carbohydrate synthesis technology platform and chemistry research facilities perfectly complement CordenPharma’s capabilities in the manufacture and supply of ...
read more
Tuesday, November 19, 2013
Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.
read more
Thursday, November 21, 2013
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Andrew Cunningham, Ph.D., as vice president of central laboratory services. Dr. Cunningham brings extensive biopharmaceutical industry experience to PPD’s central ...
read more
Friday, December 13, 2013
Okochi will have full profit and loss responsibility as well as overall accountability for all aspects of the Harlan Contract Research Services (CRS) business stream serving the Japanese chemical, agrochemical and pharmaceutical markets.
read more
Friday, December 13, 2013
Thomas Feinberg, PhD, Catalent Pharma Solutions’ Director of Development and Analytical Solutions, is to present at the forthcoming “Suitability and Compatibility for Packaging and Delivery Systems
read more
Friday, December 20, 2013
Temptime Corporation, the world’s leading
provider of time-temperature indicators to the health care industry, announced today that it
has acquired Enfield, Conn.-based William Laboratories to expand into blood temperature
monitoring solutions. ...
read more
Friday, December 20, 2013
Many Israeli pharmaceutical executives recently learned that the 505(b)(2) development process is an important tool that can significantly reduce costs and shorten the timeline for approval of new drugs, adding substantially to ROI.
read more
Friday, December 20, 2013
FlowMetric, a market leader in flow cytometry and cell sorting services, announced today that they have hired Rachel A. Bunting to lead their Business Development Unit. Ms. Bunting will be tasked with overseeing a rapidly expanding portfolio of ...
read more
Tuesday, January 07, 2014
Almac Group Limited (“Almac”) and Key Organics Limited (“Key Organics”) today announced that they have entered into an exclusive supply & marketing agreement.
read more
Tuesday, January 28, 2014
Almac’s Diagnostics business unit today announced the publication of its breast cancer chemotherapy response assay in the Journal of the National Cancer Institute (JNCI).
read more
Tuesday, January 28, 2014
a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Dariush Elahi as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology ...
read more